Rituximab and Chronic Plasmapheresis Therapy of Nephrotic Syndrome in Renal Transplantation Patients With Recurrent Focal Segmental Glomerulosclerosis

Transplantation Proceedings

Volumn 41, Issue 6, 2009, Pages 2406-2408

  Rodriguez Ferrero M ^a   Ampuero, J ^a   Anaya, F ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BASILIXIMAB; CORTICOSTEROID; EVEROLIMUS; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; HUMAN; KIDNEY DYSFUNCTION; KIDNEY TRANSPLANTATION; LONG TERM CARE; MALE; NEPHROTIC SYNDROME; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; REMISSION; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; BIOPSY; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOLOGIC FACTORS; KIDNEY TRANSPLANTATION; MALE; NEPHROTIC SYNDROME; PLASMAPHERESIS; RECURRENCE; REOPERATION;

EID: 68949200873     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.06.044     Document Type: Article

References (10)

1. Newstead C.G. Recurrent disease in renal transplants. Nephrol Dial Transplant 18 suppl 6 (2003) 68
2. Crosson J.T. Focal segmental glomerulosclerosis and renal transplantation. Transplant Proc 39 (2007) 737
3. Savin V.J., Sharma R., Sharma M., et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334 (1996) 878
4. Pradhan M., Petro J., Palmer J., et al. Early use of plasmapheresis for recurrent post-transplant FSGS. Pediatr Nephrol 18 (2003) 934
5. Genberg H., Handdon A., Wernerson A., et al. Pharmacodynamics of rituximab in kidney allotransplantation. Am J Transpl 6 (2006) 2418
6. Becker Y.T., Becker B.N., Pirsch J.D., et al. Rituximab as treatment for refractory kidney transplant rejection. Am J Transpl 4 (2004) 996
7. Pescovitz M.D., Book B.K., and Sidner R.A. Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. N Engl J Med 354 (2006) 1961
8. Goosmann J., Scheuermann E., Porubsky S., et al. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis. Transpl Int 20 (2007) 558
9. Meyer T.N., Thaiss F., and Stahl R.A.K. Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis. Transplant Int 20 (2007) 1066
10. Yabu J.M., Ho B., Scandling J.D., et al. Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomeruolosclerosis. Am J Transpl 8 (2008) 222